We’re inviting children and teens aged 6–17 who experience migraines to join a local research study. The study is evaluating a medication that’s already FDA-approved for adults with migraine, and now we’re exploring how well it works—and how safe it is—for younger patients.
If your child qualifies, they could:
Get Paid for time and travel.
Access to breakthrough treatment and study care at no cost to you.
No insurance needed.
No cost to you.
Click below to see if you qualify, takes 5 minutes